396 related articles for article (PubMed ID: 31035440)
21. Application of Theranostics in Oncology.
Lymperopoulos G; Lymperopoulos P; Alikari V; Dafogianni C; Zyga S; Margari N
Adv Exp Med Biol; 2017; 989():119-128. PubMed ID: 28971421
[TBL] [Abstract][Full Text] [Related]
22. Nanoformulations for Targeted Drug Delivery to Prostate Cancer: An Overview.
Hema S; Thambiraj S; Shankaran DR
J Nanosci Nanotechnol; 2018 Aug; 18(8):5171-5191. PubMed ID: 29458568
[TBL] [Abstract][Full Text] [Related]
23. Theranostics Aspects of Various Nanoparticles in Veterinary Medicine.
Bai DP; Lin XY; Huang YF; Zhang XF
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30352960
[TBL] [Abstract][Full Text] [Related]
24. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
Bharali DJ; Mousa SA
Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
[TBL] [Abstract][Full Text] [Related]
25. Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges.
Alshehri S; Imam SS; Rizwanullah M; Akhter S; Mahdi W; Kazi M; Ahmad J
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374391
[TBL] [Abstract][Full Text] [Related]
26. Anisotropic noble metal nanoparticles: Synthesis, surface functionalization and applications in biosensing, bioimaging, drug delivery and theranostics.
Paramasivam G; Kayambu N; Rabel AM; Sundramoorthy AK; Sundaramurthy A
Acta Biomater; 2017 Feb; 49():45-65. PubMed ID: 27915023
[TBL] [Abstract][Full Text] [Related]
27. The application of nanoparticles in diagnosis and theranostics of gastric cancer.
Li R; Liu B; Gao J
Cancer Lett; 2017 Feb; 386():123-130. PubMed ID: 27845158
[TBL] [Abstract][Full Text] [Related]
28. Janus nanoparticles in cancer diagnosis, therapy and theranostics.
Zhang Y; Huang K; Lin J; Huang P
Biomater Sci; 2019 Mar; 7(4):1262-1275. PubMed ID: 30694268
[TBL] [Abstract][Full Text] [Related]
29. Iron Oxide Nanoparticles for Breast Cancer Theranostics.
Shakil MS; Hasan MA; Sarker SR
Curr Drug Metab; 2019; 20(6):446-456. PubMed ID: 30465497
[TBL] [Abstract][Full Text] [Related]
30. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
31. Cancer Nanotechnology: Opportunities for Prevention, Diagnosis, and Therapy.
Zeineldin R; Syoufjy J
Methods Mol Biol; 2017; 1530():3-12. PubMed ID: 28150193
[TBL] [Abstract][Full Text] [Related]
32. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
[TBL] [Abstract][Full Text] [Related]
33. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
34. Cancer Therapy Based on Smart Drug Delivery with Advanced Nanoparticles.
Kong X; Liu Y; Huang X; Huang S; Gao F; Rong P; Zhang S; Zhang K; Zeng W
Anticancer Agents Med Chem; 2019; 19(6):720-730. PubMed ID: 30747081
[TBL] [Abstract][Full Text] [Related]
35. The advanced role of carbon quantum dots in nanomedical applications.
Devi P; Saini S; Kim KH
Biosens Bioelectron; 2019 Sep; 141():111158. PubMed ID: 31323605
[TBL] [Abstract][Full Text] [Related]
36. Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting.
Bonferoni MC; Gavini E; Rassu G; Maestri M; Giunchedi P
Nanomaterials (Basel); 2020 Apr; 10(5):. PubMed ID: 32365938
[TBL] [Abstract][Full Text] [Related]
37. Current state and prospects of the phytosynthesized colloidal gold nanoparticles and their applications in cancer theranostics.
Ovais M; Raza A; Naz S; Islam NU; Khalil AT; Ali S; Khan MA; Shinwari ZK
Appl Microbiol Biotechnol; 2017 May; 101(9):3551-3565. PubMed ID: 28382454
[TBL] [Abstract][Full Text] [Related]
38. Magnetic Solid Nanoparticles and Their Counterparts: Recent Advances towards Cancer Theranostics.
Cerqueira M; Belmonte-Reche E; Gallo J; Baltazar F; Bañobre-López M
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335882
[TBL] [Abstract][Full Text] [Related]
39. Recent Advances in Nanomedicine for the Diagnosis and Therapy of Liver Fibrosis.
Bai X; Su G; Zhai S
Nanomaterials (Basel); 2020 Sep; 10(10):. PubMed ID: 33003520
[TBL] [Abstract][Full Text] [Related]
40. Emergence of nanomedicine as cancer targeted magic bullets: recent development and need to address the toxicity apprehension.
Rahman M; Ahmad MZ; Kazmi I; Akhter S; Afzal M; Gupta G; Sinha VR
Curr Drug Discov Technol; 2012 Dec; 9(4):319-29. PubMed ID: 22725687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
